GlassScriptPhysician profile
Hillary I Jarnagin
NPI 1609035484
$843.34
in general payments reported to CMS, 2019-2025
21 companies · $29.14 in 2025
The $29.14 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $80.08 · 2021: $122 · 2022: $257 · 2023: $123 · 2025: $29.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $155.00 | 2019-2023 | |
| Boston Scientific Corporation | $135.59 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.02 | 2020-2025 | |
| Organon LLC | $71.27 | 2021-2023 | Nexplanon |
| Hologic Sales and Service, LLC | $47.16 | 2019-2023 | Omni Hysteroscope, Acessa Provu System, Coolseal Generator |
| Smith+Nephew, INC. | $34.87 | 2019 | |
| Medicem INC. | $34.00 | 2022 | |
| Evofem Biosciences, INC. | $28.80 | 2022 | |
| Coloplast Corp | $26.40 | 2022 | |
| Exeltis, USA INC. | $26.37 | 2021-2022 | |
| Astellas Pharma US INC | $22.02 | 2023 | Veozah |
| Lupin INC. | $18.93 | 2020 | |
| Agile Therapeutics, INC. | $17.98 | 2021 | |
| Ethicon US, LLC | $16.83 | 2019 | |
| Myovant Sciences INC. | $16.69 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $16.38 | 2022 | |
| Therapeuticsmd, INC. | $15.83 | 2020 | |
| Integra Lifesciences Corporation | $14.87 | 2021 | |
| Mayne Pharma Commercial LLC | $12.90 | 2022 | |
| Avion Pharmaceuticals | $11.40 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hillary Jarnagin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.